Unknown

Dataset Information

0

Vitamin K3 derivative induces apoptotic cell death in neuroblastoma via downregulation of MYCN expression.


ABSTRACT: Neuroblastoma is a pediatric malignant tumor arising from the sympathetic nervous system. The patients with high-risk neuroblastomas frequently exhibit amplification and high expression of the MYCN gene, resulting in worse clinical outcomes. Vitamin K3 (VK3) is a synthetic VK-like compound that has been known to have antitumor activity against various types of cancers. In the present study, we have asked whether VK3 and its derivative, VK3-OH, could have the antitumor activity against neuroblastoma-derived cells. Based on our results, VK3-OH strongly inhibited cell proliferation and induced apoptotic cell death compared to VK3. Treatment of MYCN-driven neuroblastoma cells with VK3-OH potentiated tumor suppressor p53 accompanied by downregulation of anti-apoptotic Bcl-2 and Mcl-1. Interestingly, VK3-OH also suppressed the MYCN at mRNA and protein levels. Furthermore, we found downregulation of LIN28B following VK3-OH treatment in MYCN-amplified and overexpressed neuroblastoma cells. Collectively, our current findings strongly suggest that VK3-OH provides a potential therapeutic strategy for patients with MYCN-driven neuroblastomas.

SUBMITTER: Yoda H 

PROVIDER: S-EPMC6895568 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vitamin K3 derivative induces apoptotic cell death in neuroblastoma via downregulation of MYCN expression.

Yoda Hiroyuki H   Nakayama Toshimitsu T   Miura Motofumi M   Toriyama Masaharu M   Motohashi Shigeyasu S   Suzuki Takashi T  

Biochemistry and biophysics reports 20191031


Neuroblastoma is a pediatric malignant tumor arising from the sympathetic nervous system. The patients with high-risk neuroblastomas frequently exhibit amplification and high expression of the MYCN gene, resulting in worse clinical outcomes. Vitamin K3 (VK3) is a synthetic VK-like compound that has been known to have antitumor activity against various types of cancers. In the present study, we have asked whether VK3 and its derivative, VK3-OH, could have the antitumor activity against neuroblast  ...[more]

Similar Datasets

| S-EPMC6915131 | biostudies-literature
| S-EPMC3972687 | biostudies-literature
| S-EPMC5915064 | biostudies-literature
| S-EPMC5582212 | biostudies-literature
| S-EPMC2474548 | biostudies-literature
| S-EPMC3887865 | biostudies-literature
| S-EPMC7321810 | biostudies-literature
| S-EPMC5913307 | biostudies-literature
| S-EPMC3702291 | biostudies-literature
| S-EPMC3923752 | biostudies-literature